Qube Research & Technologies (QRT)
MET icon

Qube Research & Technologies (QRT)’s MetLife MET Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio MET Stock Details MET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.46K Sell
100
-4,900
-98% -$395K ﹤0.01% 3302
2026
Q1 		$354K Sell
5,000
-6,200
-55% -$464K ﹤0.01% 2834
2025
Q4 		$884K Sell
11,200
-3,800
-25% -$301K ﹤0.01% 2601
2025
Q3 		$1.24M Buy
15,000
+500
+3% +$39.3K ﹤0.01% 2430
2025
Q2 		$1.17M Buy
14,500
+9,300
+179% +$718K ﹤0.01% 2401
2025
Q1 		$418K Buy
5,200
+3,800
+271% +$316K ﹤0.01% 2606
2024
Q4 		$115K Buy
+1,400
New +$116K ﹤0.01% 2961
2024
Q3 		– Sell
-1,500
Closed -$105K – 3801
2024
Q2 		$105K Buy
+1,500
New +$107K ﹤0.01% 2595
2023
Q4 		– Sell
-2,400
Closed -$151K – 4579
2023
Q3 		$151K Buy
+2,400
New +$149K ﹤0.01% 2512

Other funds holding MET

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Qube Research & Technologies (QRT)'s MET Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its MetLife (MET) stake by 95% in Q2 2026, selling an estimated $105M and leaving 71,580 shares worth $6.06M. The position accounts for 0.01% of the portfolio, ranked #1540.

Qube Research & Technologies (QRT) first reported a position in MET in Q1 2018 and has held it in 21 quarters since. The position peaked at $126M in Q4 2023. 1,448 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Qube Research & Technologies (QRT) held 71,580 shares of MetLife worth $6.06M as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 1,303,273 MetLife shares in Q2 2026, an estimated $105M.
  • MetLife made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1540 holding.
  • Qube Research & Technologies (QRT) first reported a position in MetLife in Q1 2018 and has held it in 21 quarters since.
  • Qube Research & Technologies (QRT)'s MetLife position peaked at $126M in Q4 2023.
  • 1,448 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.